1-11 of 11
hypertension
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and safety of copanlisib in patients with relapsed or refractory marginal zone lymphoma

Clinical Trials & Observations
Panayiotis Panayiotidis, George A. Follows, Luigina Mollica, Arnon Nagler, Muhit Özcan, Armando Santoro, Don Stevens, David Trevarthen, Florian Hiemeyer, Jose Garcia-Vargas, Barrett H. Childs, Pier Luigi Zinzani, Martin Dreyling
Journal: Blood Advances
Blood Adv (2021) 5 (3): 823–828.
https://doi.org/10.1182/bloodadvances.2020002910
Published: 2021
Includes: Supplemental data
Journal Articles

Apohemoglobin-haptoglobin complexes attenuate the hypertensive response to low-molecular-weight polymerized hemoglobin

Donald A. Belcher, Carlos Munoz, Ivan S. Pires, Alexander T. Williams, Pedro Cabrales, Andre F. Palmer
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2739–2750.
https://doi.org/10.1182/bloodadvances.2020002045
Published: 2020
Journal Articles

Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome

Clinical Trials & Observations
Je-Hwan Lee, Stefan Faderl, John M. Pagel, Chul Won Jung, Sung-Soo Yoon, Animesh D. Pardanani, Pamela S. Becker, Howard Lee, Jeongeun Choi, Kyoungjune Lee, Minkyoung Kim, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2020) 4 (9): 2032–2043.
https://doi.org/10.1182/bloodadvances.2019000757
Published: 2020
Includes: Supplemental data
Journal Articles

Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL

Clinical Trials & Observations
Preetesh Jain, Shaojun Zhang, Rashmi Kanagal-Shamanna, Chi Young Ok, Krystle Nomie, Graciela Nogueras Gonzalez, Omarya Gonzalez-Pagan, Holly A. Hill, Hun Ju Lee, Luis Fayad, Jason Westin, Loretta Nastoupil, Frederick Hagemeister, Wendy Chen, Onyeka Oriabure, Maria Badillo, Changying Jiang, Yao Yixin, Shaoying Li, Guilin Tang, C. Cameron Yin, Keyur P. Patel, Leonard Jeffrey Medeiros, Ranjit Nair, Sairah Ahmed, Swaminathan P. Iyer, Selvi Thirumurthi, Richard Champlin, Guofan Xu, Pan Tinsu, David Santos, Ruiping Wang, Guangchun Han, Jianhua Zhang, Xingzhi Song, Sattva Neelapu, Jorge Romaguera, Andy Futreal, Christopher Flowers, Nathan Fowler, Linghua Wang, Michael L. Wang
Journal: Blood Advances
Blood Adv (2020) 4 (6): 1038–1050.
https://doi.org/10.1182/bloodadvances.2019001396
Published: 2020
Includes: Supplemental data
Journal Articles

Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia

Clinical Trials & Observations
Onyee Chan, Chetasi Talati, Leidy Isenalumhe, Samantha Shams, Lisa Nodzon, Michael Fradley, Kendra Sweet, Javier Pinilla-Ibarz
Journal: Blood Advances
Blood Adv (2020) 4 (3): 530–538.
https://doi.org/10.1182/bloodadvances.2019000268
Published: 2020
Journal Articles

Metabolic syndrome increases risk of venous thromboembolism recurrence after acute deep vein thrombosis

Clinical Trials & Observations
Lauren K. Stewart, Jeffrey A. Kline
Journal: Blood Advances
Blood Adv (2020) 4 (1): 127–135.
https://doi.org/10.1182/bloodadvances.2019000561
Published: 2020
Journal Articles

Long-term safety of single-agent ibrutinib in patients with chronic lymphocytic leukemia in 3 pivotal studies

Clinical Trials & Observations
Steven E. Coutre, John C. Byrd, Peter Hillmen, Jacqueline C. Barrientos, Paul M. Barr, Stephen Devereux, Tadeusz Robak, Thomas J. Kipps, Anna Schuh, Carol Moreno, Richard R. Furman, Jan A. Burger, Michael O’Dwyer, Paolo Ghia, Rudolph Valentino, Stephen Chang, James P. Dean, Danelle F. James, Susan M. O’Brien
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1799–1807.
https://doi.org/10.1182/bloodadvances.2018028761
Published: 2019
Includes: Supplemental data
Journal Articles

Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs

Clinical Trials & Observations
Preetesh Jain, Hagop Kantarjian, Prajwal C. Boddu, Graciela M. Nogueras-González, Srdan Verstovsek, Guillermo Garcia-Manero, Gautam Borthakur, Koji Sasaki, Tapan M. Kadia, Princy Sam, Hycienth Ahaneku, Susan O’Brien, Zeev Estrov, Farhad Ravandi, Elias Jabbour, Jorge E. Cortes
Journal: Blood Advances
Blood Adv (2019) 3 (6): 851–861.
https://doi.org/10.1182/bloodadvances.2018025874
Published: 2019
Includes: Supplemental data
Journal Articles

Prediction of cardiovascular disease among hematopoietic cell transplantation survivors

Clinical Trials & Observations
Saro H. Armenian, Dongyun Yang, Jennifer Berano Teh, Liezl C. Atencio, Alicia Gonzales, F. Lennie Wong, Wendy M. Leisenring, Stephen J. Forman, Ryotaro Nakamura, Eric J. Chow
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1756–1764.
https://doi.org/10.1182/bloodadvances.2018019117
Published: 2018
Includes: Supplemental data
Journal Articles

Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trials

Clinical Trials & Observations
Ajai Chari, A. Keith Stewart, Stuart D. Russell, Philippe Moreau, Joerg Herrmann, Jose Banchs, Roman Hajek, John Groarke, Alexander R. Lyon, George N. Batty, Sunhee Ro, Mei Huang, Karim S. Iskander, Daniel Lenihan
Journal: Blood Advances
Blood Adv (2018) 2 (13): 1633–1644.
https://doi.org/10.1182/bloodadvances.2017015545
Published: 2018
Includes: Supplemental data
Journal Articles

Low fetal hemoglobin percentage is associated with silent brain lesions in adults with homozygous sickle cell disease

Clinical Trials & Observations
David Calvet, Titien Tuilier, Nicolas Mélé, Guillaume Turc, Anoosha Habibi, Nassim Ait Abdallah, Loubna Majhadi, François Hemery, Myriam Edjlali, Frédéric Galacteros, Pablo Bartolucci
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2503–2509.
https://doi.org/10.1182/bloodadvances.2017005504
Published: 2017